0001209191-18-040506.txt : 20180702
0001209191-18-040506.hdr.sgml : 20180702
20180702192659
ACCESSION NUMBER: 0001209191-18-040506
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180628
FILED AS OF DATE: 20180702
DATE AS OF CHANGE: 20180702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chen Ivan
CENTRAL INDEX KEY: 0001743729
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14468
FILM NUMBER: 18934419
MAIL ADDRESS:
STREET 1: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PURE BIOSCIENCE, INC.
CENTRAL INDEX KEY: 0001006028
STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890]
IRS NUMBER: 330530289
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
BUSINESS PHONE: 619-596-8600
MAIL ADDRESS:
STREET 1: 1725 GILLESPIE WAY
CITY: EL CAJON
STATE: CA
ZIP: 92020
FORMER COMPANY:
FORMER CONFORMED NAME: PURE BIOSCIENCE
DATE OF NAME CHANGE: 20031029
FORMER COMPANY:
FORMER CONFORMED NAME: PURE BIOSCIENCES
DATE OF NAME CHANGE: 20031029
FORMER COMPANY:
FORMER CONFORMED NAME: INNOVATIVE MEDICAL SERVICES
DATE OF NAME CHANGE: 19960122
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-28
0
0001006028
PURE BIOSCIENCE, INC.
PURE
0001743729
Chen Ivan
1725 GILLESPIE WAY
EL CAJON
CA
92020
1
0
0
0
Common Stock
2018-06-28
4
A
0
150000
0.00
A
150000
D
Stock Option (Right to Buy)
0.652
2018-06-28
4
A
0
200000
0.00
A
2028-06-28
Common Stock
200000
200000
D
Represents the issuance of restricted stock units (the "RSUs"). The RSUs vest and become exercisable as follows: (i) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the RSUs will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.
The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2019 or January 15, 2019 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2020 or January 15, 2020.
/s/ Ivan Chen
2018-07-02